Drug intelligence / Profile preview

Bushentongluo

Development stage
Preclinical
Lead developer
Anhui University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Bushentongluo (BSTL) is a Traditional Chinese Medicine (TCM) recipe specifically designed to treat rheumatoid arthritis (RA) and mitigate associated bone destruction. Its mechanism of action involves the suppression of systemic inflammation and the modulation of the **NF-κB/RANK/RANKL signaling pathway**. Specifically, BSTL down-regulates the expression of **NF-κB p65**, **RANK**, and **RANKL** proteins, which are critical mediators of osteoclast differentiation and bone erosion. Simultaneously, it up-regulates **osteoprotegerin (OPG)**, a decoy receptor that inhibits RANKL-induced bone resorption. Preclinical studies indicate that BSTL significantly reduces levels of pro-inflammatory cytokines, including **TNF-α**, **IL-1β**, and **IL-18**, as well as collagen-specific antibodies, thereby alleviating arthritis symptoms and protecting joint integrity.

Other names
Bushentongluo recipeBushentongluo decoctionBushen Tongluo
02

Targets

OPG (Osteoprotegerin)RELA (Nuclear Factor Kappa B Subunit p65)TNFA (Tumor necrosis factor alpha (soluble))TNFRSF11A (RANK)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Bushentongluo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bushentongluo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call